Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

36
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
36
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Drug Therapy01:28

Drug Therapy

37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
37
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

119
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
119
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Borderline personality disorder and other psychiatric, somatic, and behavioral conditions: a nationwide family study.

Translational psychiatry·2026
Same author

'Sustainable Choices' - An intervention to promote climate change mitigation behaviours: Study protocol for a randomized controlled trial.

PloS one·2026
Same author

A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden.

Molecular psychiatry·2025
Same author

Assessing the association between child maltreatment and chronic pain: a cross-sectional co-twin control study.

Pain·2025
Same author

Publisher Correction: Genome-wide association meta-analysis of childhood ADHD symptoms and diagnosis identifies new loci and potential effector genes.

Nature genetics·2025
Same author

Genome-wide association meta-analysis of childhood ADHD symptoms and diagnosis identifies new loci and potential effector genes.

Nature genetics·2025
Same journal

Correction: How universal quality standards in intervention meta-analyses favor evidence from medical over psychosocial studies.

European child & adolescent psychiatry·2026
Same journal

Incidence of ADHD diagnoses and medication initiation among children and adolescents in Norway from 2016-2024.

European child & adolescent psychiatry·2026
Same journal

Executive function development between ages 2 and 6 in children exposed to threatened preterm labor.

European child & adolescent psychiatry·2026
Same journal

Brain correlates of cognitive reserve in offspring of patients with schizophrenia or bipolar disorder.

European child & adolescent psychiatry·2026
Same journal

Effect of methylphenidate on body mass index in children and adolescents in relation to baseline weight status.

European child & adolescent psychiatry·2026
Same journal

Dissociable EEG connectivity patterns reflect the latent general and specific dimensions of ADHD in children and adolescents.

European child & adolescent psychiatry·2026
See all related articles

Related Experiment Video

Updated: May 30, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.5K

Can response to ADHD medication be predicted?

Maria M Lilja1, Paul Lichtenstein2, Eva Serlachius3,4

  • 1Department of Clinical Sciences, Child and Adolescent Psychiatry, Umea University, Umea, Sweden. Maria.lilja@umu.se.

European Child & Adolescent Psychiatry
|January 28, 2025
PubMed
Summary
This summary is machine-generated.

Predicting ADHD medication effectiveness in children is challenging. This study found no reliable clinical factors to predict treatment outcomes in a large real-world cohort of pediatric patients.

Keywords:
ADHDEffectPharmacological treatmentPredictorsResponse

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.7K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.2K

Related Experiment Videos

Last Updated: May 30, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.5K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.7K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.2K

Area of Science:

  • Pediatric Pharmacology
  • Neurodevelopmental Disorders
  • Clinical Trial Methodology

Background:

  • Predicting the pharmacological response to Attention Deficit Hyperactivity Disorder (ADHD) medication in children and adolescents remains a significant clinical challenge.
  • Existing research has not identified reliable predictors for treatment efficacy in this population.
  • Real-world evidence is crucial for understanding treatment outcomes beyond controlled trial settings.

Purpose of the Study:

  • To identify clinically relevant factors that predict the pharmacological treatment effect of ADHD medication in a large, prospective, real-world cohort of children and adolescents.
  • To evaluate the association between various baseline characteristics and treatment response.
  • To determine if factors like symptom severity, comorbidities, or demographics influence medication effectiveness.

Main Methods:

  • A prospective cohort study of 638 children and adolescents (aged 6-17) diagnosed with ADHD was conducted.
  • Participants were evaluated at baseline and three months after initiating ADHD medication.
  • Outcome was measured by the reduction in the SNAP-IV (Swanson Nolan and Pelham teacher and parent rating scale) score, with responders defined by ≥40% reduction.

Main Results:

  • Initial analysis using multinomial logistic regression suggested associations between ADHD symptom severity, geographical region, relative age, and treatment continuation with response outcome.
  • However, subsequent validation using Bootstrap Forest analysis found none of the examined variables to be significant predictors.
  • The study could not identify clinically relevant factors that reliably predict pharmacological treatment outcomes in this naturalistic cohort.

Conclusions:

  • This large-scale, real-world study failed to identify reliable predictors for ADHD medication response in children and adolescents.
  • The findings highlight the complexity of ADHD treatment and the need for further research into personalized medicine approaches.
  • Clinicians currently lack robust tools to predict which children will respond best to specific ADHD pharmacological interventions.